IL72471A - Pharmaceutical compositions containing 2-(hetero)aryl-quinoline-4-carboxylic acid and derivatives thereof,certain such novel compounds and their preparation - Google Patents

Pharmaceutical compositions containing 2-(hetero)aryl-quinoline-4-carboxylic acid and derivatives thereof,certain such novel compounds and their preparation

Info

Publication number
IL72471A
IL72471A IL72471A IL7247184A IL72471A IL 72471 A IL72471 A IL 72471A IL 72471 A IL72471 A IL 72471A IL 7247184 A IL7247184 A IL 7247184A IL 72471 A IL72471 A IL 72471A
Authority
IL
Israel
Prior art keywords
quinoline
hetero
aryl
derivatives
preparation
Prior art date
Application number
IL72471A
Other languages
English (en)
Other versions
IL72471A0 (en
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of IL72471A0 publication Critical patent/IL72471A0/xx
Publication of IL72471A publication Critical patent/IL72471A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL72471A 1983-07-22 1984-07-20 Pharmaceutical compositions containing 2-(hetero)aryl-quinoline-4-carboxylic acid and derivatives thereof,certain such novel compounds and their preparation IL72471A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631983A 1983-07-22 1983-07-22
US60510484A 1984-04-30 1984-04-30

Publications (2)

Publication Number Publication Date
IL72471A0 IL72471A0 (en) 1984-11-30
IL72471A true IL72471A (en) 1988-11-15

Family

ID=27058797

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72471A IL72471A (en) 1983-07-22 1984-07-20 Pharmaceutical compositions containing 2-(hetero)aryl-quinoline-4-carboxylic acid and derivatives thereof,certain such novel compounds and their preparation

Country Status (16)

Country Link
EP (1) EP0133244B1 (fi)
AU (1) AU583793B2 (fi)
CA (1) CA1288436C (fi)
DE (1) DE3483704D1 (fi)
DK (1) DK358784A (fi)
ES (1) ES534509A0 (fi)
FI (1) FI86987C (fi)
GR (1) GR82234B (fi)
HK (1) HK142395A (fi)
HU (1) HU194832B (fi)
IE (1) IE57627B1 (fi)
IL (1) IL72471A (fi)
NO (1) NO167510C (fi)
NZ (1) NZ208966A (fi)
PT (1) PT78960B (fi)
SU (2) SU1393314A3 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
WO1989006227A1 (en) * 1987-12-28 1989-07-13 The Dow Chemical Company Phenoxyphenoxypropionates, intermediates thereof and methods of preparation
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
US4918077A (en) * 1989-01-25 1990-04-17 E. I. Du Pont De Nemours & Co., Inc. 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
DE3905339A1 (de) * 1989-02-22 1990-09-06 Basf Ag Chinolin-4-carbonsaeurederivate und deren verwendung
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
IL133007A (en) * 1997-05-28 2005-06-19 Aventis Pharma Inc Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
ZA9811672B (en) * 1997-12-19 2000-06-19 Lilly Co Eli Hypoglycemic imidazoline compounds.
EP1541149A1 (en) * 2002-06-26 2005-06-15 Kyowa Hakko Kogyo Co., Ltd. Phosphodiesterase inhibitor
US8232310B2 (en) 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
WO2013155341A1 (en) 2012-04-12 2013-10-17 Georgetown University Methods and compositions for treating ewings sarcoma family of tumors
AU2014340398A1 (en) 2013-10-24 2016-06-09 Georgetown University Methods and compositions for treating cancer
MX2016006678A (es) 2013-11-22 2016-09-13 Genzyme Corp Nuevos metodos para tratar enfermedades neurodegenerativas.
CA2961781C (en) 2014-10-09 2023-10-03 Oncternal Therapeutics, Inc. Indolinone compounds and uses thereof
ES2823190T3 (es) 2016-03-31 2021-05-06 Oncternal Therapeutics Inc Análogos de indolina y usos de los mismos
CN114569606B (zh) 2016-07-29 2024-04-19 英克特诺治疗公司 吲哚啉酮化合物的用途
JP2023512413A (ja) * 2019-12-26 2023-03-27 オハイオ ステート イノベーション ファウンデーション ジヒドロオロト酸デヒドロゲナーゼの阻害のための方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502610A (fi) * 1950-04-18
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds

Also Published As

Publication number Publication date
HK142395A (en) 1995-09-15
DE3483704D1 (de) 1991-01-17
PT78960A (en) 1984-08-01
HU194832B (en) 1988-03-28
DK358784A (da) 1985-01-23
ES8507498A1 (es) 1985-09-01
SU1452480A3 (ru) 1989-01-15
DK358784D0 (da) 1984-07-20
EP0133244A3 (en) 1985-12-11
CA1288436C (en) 1991-09-03
PT78960B (en) 1986-10-20
FI86987B (fi) 1992-07-31
HUT35248A (en) 1985-06-28
ES534509A0 (es) 1985-09-01
AU3085284A (en) 1985-01-24
EP0133244A2 (en) 1985-02-20
GR82234B (fi) 1984-12-13
EP0133244B1 (en) 1990-12-05
NO167510C (no) 1991-11-13
FI86987C (fi) 1992-11-10
NO167510B (no) 1991-08-05
IE841873L (en) 1985-01-22
IL72471A0 (en) 1984-11-30
AU583793B2 (en) 1989-05-11
FI842928A0 (fi) 1984-07-20
FI842928A (fi) 1985-01-23
SU1393314A3 (ru) 1988-04-30
NZ208966A (en) 1986-12-05
NO842969L (no) 1985-01-23
IE57627B1 (en) 1993-02-10

Similar Documents

Publication Publication Date Title
PH18918A (en) 2-acyl-azabicycloalkane-3-carboxylic acid derivatives,pharmaceutical compositions containing these compounds and their use
IL69347A (en) Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69601A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75586A0 (en) Pharmaceutical compositions containing indole-2-alkanoic acids and derivatives thereof,and certain such novel compounds
IL65963A0 (en) Bis-triazole derivative and salts thereof,their preparation and pharmaceutical compositions containing them
IL73904A (en) Benzoic acid derivatives and related compounds,their production and pharmaceutical compositions containing them
IL82421A0 (en) Pharmaceutical compositions containing heterocyclic compounds,certain such novel compounds and their preparation
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL72471A (en) Pharmaceutical compositions containing 2-(hetero)aryl-quinoline-4-carboxylic acid and derivatives thereof,certain such novel compounds and their preparation
IL70966A0 (en) Imidazoline derivatives and related compounds,their preparation and pharmaceutical compositions containing them
ZA859035B (en) Amino-salicylic acid derivatives,salts thereof,process for their preparation and pharmaceutical compositions containing them
DE3273783D1 (en) Novel piperidine derivatives, processes for preparation thereof and pharmaceutical compositions containing same
IL68323A (en) Alkanoyl-3-(substituted alkoxy)-phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL73427A (en) 5-substituted-3-(hetero)aralkyl-oxazolidine-2-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
IL87435A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL64732A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3273629D1 (en) New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
IL81410A (en) Pharmaceutical compositions containing substituted n-arylmethylamine derivatives,certain such novel compounds and their preparation
IL70508A (en) Pharmaceutical compositions containing aralkyltriazole derivatives,some such novel compounds and their preparation
IL68015A0 (en) Fungicidal compositions containing 2-cyano-3-amino-2-propenoic acid derivatives,certain such novel compounds and their preparation
IL59655A (en) 2-(2-phenyl-6-benzothiazolyl)propionic acid derivatives,their preparation and pharmaceutical compositions containing them
IL65169A0 (en) Substituted trifluoromethylphenyltetrahydropyridines and salts thereof,their preparation and pharmaceutical compositions containing them
IL71078A (en) Pharmaceutical compositions comprising n-aminoethyl-benzamide derivatives,certain such novel compounds and their preparation
IL68520A0 (en) 5-oxo-2-pyrrolidinepropanoic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL70273A (en) N-(substituted alkyl)acridanone-2-thiazole-2-yl-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees